Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability
Sign Up to like & getrecommendations! Published in 2022 at "Brain"
DOI: 10.1093/brain/awac296
Abstract: Abstract Prenatal exposure to the anti-seizure medication sodium valproate (VPA) is associated with an increased risk of adverse postnatal neurodevelopmental outcomes, including lowered intellectual ability, autism spectrum disorder and attention-deficit hyperactivity disorder. In this study,… read more here.
Keywords: valproate; vpa; neurodevelopmental disability; gene expression ... See more keywords